secwatch.observer — SEC 8-K summary
======================================

Issuer:     NantHealth, Inc. (—)
CIK:        0001566469
Form:       8-K
Filed at:   2023-12-21T23:59:59+00:00
Accession:  0001566469-23-000078
Event type: debt
Sentiment:  negative
Materiality: 0.80
Item codes: 1.01, 2.03, 3.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NantHealth restructures $75M notes with Highbridge via $12.5M Nant Capital loan
-------------------------------------------------------------------------------

- Settlement exchanges $75M convertible notes for ~$10M cash and ~$68M senior secured term loans pari passu.
- Borrowed $12.5M first lien term loan from Nant Capital to pay Highbridge interest and fees.
- Interest rate on credit agreement reduced from 13% to 8.5%; maturity extended to December 15, 2025.
- Nant Capital to provide $7.5M Tranche A and at least $17.5M Tranche B subordinated notes (8.5%, due Dec 2026).
- Proceeds fund operating plan and partially repay Highbridge exchange term loans.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1566469/000156646923000078/0001566469-23-000078-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1566469/000156646923000078/nh-20231215.htm
  HTML page:      https://secwatch.observer/filing/0001566469-23-000078

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer